1-3 of 3
J L Murray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.

Free
M W Pride, S Shuey, A Grillo-Lopez, G Braslawsky, M Ross, S S Legha, O Eton, A Buzaid, C Ioannides, J L Murray
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (10): 2363–2370.
Published: 01 October 1998
View articletitled, Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.
Open the PDF for Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen. in another window
Journal Articles

Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients.

Free
T M Tuttle, B W Anderson, W E Thompson, J E Lee, A Sahin, T L Smith, K H Grabstein, J T Wharton, C G Ioannides, J L Murray
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (8): 2015–2024.
Published: 01 August 1998
View articletitled, Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients.
Open the PDF for Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. in another window
Journal Articles

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Free
D J Macey, E J Grant, L Kasi, M G Rosenblum, H Z Zhang, R L Katz, P T Rieger, D LeBherz, M South, J W Greiner, J Schlom, D A Podoloff, J L Murray
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1547–1555.
Published: 01 September 1997
View articletitled, Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Open the PDF for Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial. in another window